BackAeglea BioTherapeutics Overview

Aeglea BioTherapeutics Operating Income

Operating Income for AGLE.

Quarterly Operating Income

$-45641000.00
↓ 14.8% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-201636000.00
↑ 21.99% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin